Join

Compare · ECPG vs HQH

ECPG vs HQH

Side-by-side comparison of Encore Capital Group Inc (ECPG) and abrdn Healthcare Investors Shares of Beneficial Interest (HQH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ECPG and HQH operate in Finance Companies (Finance), so they compete in similar markets.
  • ECPG is the larger of the two at $2.17B, about 1.9x HQH ($1.12B).
  • ECPG has been more active in the news (5 items in the past 4 weeks vs 2 for HQH).
  • ECPG has more recent analyst coverage (5 ratings vs 0 for HQH).
MetricECPGHQH
Company
Encore Capital Group Inc
abrdn Healthcare Investors Shares of Beneficial Interest
Price
-
-
Market cap
$2.17B
$1.12B
1M return
-
-
1Y return
-
-
Industry
Finance Companies
Finance Companies
Exchange
NASDAQ
NYSE
IPO
1987
News (4w)
5
2
Recent ratings
5
0
ECPG

Encore Capital Group Inc

Encore Capital Group, Inc., a specialty finance company, together with its subsidiaries, provides debt recovery solutions and other related services for consumers across a range of financial assets worldwide. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value, as well as manages them by working with individuals as they repay their obligations and works toward financial recovery. It is also involved in the early stage collections, business process outsourcing, contingent collections, trace services, and litigation activities; and provision of debt servicing and other portfolio management services to credit originator for non-performing loans. Encore Capital Group, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

HQH

abrdn Healthcare Investors Shares of Beneficial Interest

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Latest ECPG

Latest HQH